HOPE and extension of the indications for ACE inhibitors? Heart Outcomes Prevention Evaluation
Chaturvedi, N.
Lancet 355(9200): 246-247
2000
ISSN/ISBN: 0140-6736 PMID: 10675066 Document Number: 514748
Document emailed within 1 workday
Related Documents
Kleinert, S. 1999: HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation Lancet 354(9181): 841Hutcheon, S.D.; Gillespie, N.D.; McMurdo, M.E.; Struthers, A.D. 2000: HOPE and elderly patients attending geriatric day hospital. Heart Outcomes Prevention Evaluation Study Lancet 356(9228): 511-512
Burke, F.J. 2003: From extension for prevention to prevention of extension: (minimal intervention dentistry) Dental Update 30(9): 492-8 500 502
Mateu, J. 1984: Nouveaux lébiens d'Afrique appartenant aux genres Philorhizus Hope et Syntomus Hope (Coleoptera, Carabidae) - New Lebiidae of the genus Philorhizus Hope et Syntomus Hope Nouv. Rev. Entomol 1(4): 339-346
Kleber, F.X.; Baumann, G. 1993: Significance of treatment of early forms and prevention of heart failure. Value of ACE inhibitors in therapy after myocardial infarct Acta Medica Austriaca 20(4): 95-99
Phipps, L. 1997: Psychiatric evaluation and outcomes in candidates for heart transplantation Clinical and Investigative Medicine 20(6): 388-395
Muñoz, M.A.; Subirana, I.; Ramos, R.; Franzi, A.; Vila, J.; Marrugat, J. 2008: Efficacy of an intensive prevention programme of coronary heart disease: 5 year follow-up outcomes Medicina Clinica 130(14): 521-525
Walczak, B.; Ruzyllo, W. 1973: Heart catheterization and selective angiocardiography in evaluation of indications for re-surgery of mitral valve stenosis Kardiologia Polska 16(2): 139-146
Fabbrocini, G.; Cacciapuoti, S. 2018: Evaluation, Prevention, and Management of Acne Scars: Issues, Strategies, and Enhanced Outcomes Journal of Drugs in Dermatology: Jdd 17(12): S44-S48
Martens, L.L.; Guibert, R. 1994: Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease Clinical Therapeutics 16(6): 1052-62; discussion 1036
Cowan, F.M.; Langhaug, L.F.; Mashungupa, G.P.; Nyamurera, T.; Hargrove, J.; Jaffar, S.; Peeling, R.W.; Brown, D.W.G.; Power, R.; Johnson, A.M.; Stephenson, J.M.; Bassett, M.T.; Hayes, R.J. 2002: School based HIV prevention in Zimbabwe: feasibility and acceptability of evaluation trials using biological outcomes Aids 16(12): 1673-1678
Vanik, M.; Wabrosch, G. 1992: Extension of the indications for extracorporeal shock wave lithotripsy in a 3-year period Orvosi Hetilap 133(7): 395-398
Heinrich, B. 2005: Therapeutic outcomes in systemic lymphatic diseases and plasmacytoma. new hope for palliative patients MMW Fortschritte der Medizin 147(24): 23
Hirose, S.; Mano, K.; Kataoka, K.; Kitamura, M.; Tsutsui, N.; Ohara, T.; Kimura, H. 1988: Extension and reduction of surgery of cancer occupying mainly the upper third part of the stomach--indications and limitations Nihon Geka Gakkai Zasshi 89(9): 1517-1520
Mani, M.K. 2010: A glimmer of hope for prevention National Medical Journal of India 23(2): 109-110
Nambiar, D.; Nguyen, M.Huong.; Giang, L.Minh.; Hirsch, J.; Parker, R.G. 2013: Tabula diptycha: differential HIV knowledge, stigma and intended behavioural outcomes amongst visitors at Vietnam's Pain and Hope exhibition Global Public Health 8 Suppl. 1: S46-S60
Vermund, S.H.; Hayes, R.J. 2013: Combination prevention: new hope for stopping the epidemic Current Hiv/Aids Reports 10(2): 169-186
Osborne, J.W.; Summitt, J.B. 1998: Extension for prevention: is it relevant today? American Journal of Dentistry 11(4): 189-196
Bouvier, C.A. 1975: Indications and contraindications for protease inhibitors Schweizerische Medizinische Wochenschrift 105(37): 1191-1195
Tsuyuki, R.T.; Yusuf, S.; Rouleau, J.L.; Maggioni, A.P.; McKelvie, R.S.; Wiecek, E.M.; Wang, Y.; Pogue, J.; Teo, K.K.; White, M.; Avezum, A.; Latini, R.; Held, P.; Lindgren, E.; Probstfield, J. 1997: Combination neurohormonal blockade with ACE inhibitors, angiotensin Ii antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study Canadian Journal of Cardiology 13(12): 1166-1174